INTRODUCTION
Staphylococcus aureus (S. aureus) remains to be one of the leading causes of iatrogenic and communityassociated infections, causing high mortality and limited therapeutics (Tong et al., 2015; Zheng et al., 2017) . The increasing emergence and spreading of antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) make its treatment more challenging, thereby underscoring a pressing need for developing antimicrobial therapies. A critical tenant in the battle against staphylococcal infections is to further understand host defensive machinery (Parker and Prince, 2012; Miller and Cho, 2011) .
Macrophages are the frontline of host defense with the ability to recognize, uptake, and finally eliminate the invading pathogens. Also, they are required for tissue repair, regeneration, and maintaining barrier integrity Preston et al., 2019) . The importance of macrophages in combating against staphylococcal infection was highlighted by the study using Rag1 À/À mice, which exhibited the intact anti-bacterial immune responses despite lack of mature T and B cells (Schmaler et al., 2011) . However, the depletion of macrophages substantially affected host defensive response and impeded bacterial clearance, indicating that the innate rather than the adaptive immune cells were required for controlling infection (Chan et al., 2018) . Furthermore, the adoptive experiments revealed that protection against staphylococcus re-infection was primarily mediated by macrophages, which would release copious proinflammatory cytokines, chemokines, and anti-microbial peptides (AMPs) and recruit immune cells to coordinately combat pathogens (Vaishnava et al., 2011) .
Among these proinflammatory cytokines, interleukin (IL)-17 and IL-22 have gained much attention due to their leading roles in mucosal immunity and tissue repair Dudakov et al., 2015) . Evidences have shown that IL-17 and IL-22 can induce the expression of antimicrobial proteins such as regenerating islet-derived protein 3 (Reg3) and defensins, which would potentially kill or inactivate microorganisms and simultaneously promote tissue repairing and regeneration (Loonen et al., 2014; Sechet et al., 2018) . Accordingly, loss of IL-17 or IL-22 led to higher lung bacterial burdens and exaggerated staphylococcus pneumonia (Cho et al., 2010; Treerat et al., 2017) . IL-17 and IL-22 have been thought to release from lymphoid cells, but recent data indicated that macrophages also produced IL-22, IL-23, and subsequently IL-17, which played an indispensible role in regulating macrophages function. As a result, the inactivation of the IL-23-IL-22 signaling caused the defection in macrophages activation and differentiation, leading to exacerbated bacterial pneumonia and higher mortality (Longman et al., 2014) . Given the preponderance of the IL-17/IL-22/IL-23 pathway in host defensive response, it is vital to clarify the mechanism involved and the factors with the regulatory potential.
Signal transducer and activator of transcription 3 (STAT3) is a master factor that has a key role in both immune and inflammatory responses. Activation of STAT3 is the key signaling event required for the generation of IL-17 and IL-22 (Villarino et al., 2017) . In response to infectious or inflammatory signals, STAT3 undergoes phosphorylation, homo-dimerization, and nuclear translocation to initiate the transcription of IL-22 and IL-17 (Ciofani et al., 2012) . Loss-of-functional mutation of STAT3 led to impaired IL-17 and IL-22 expression and rendered hosts more susceptible to candidiasis and staphylococcal infection (Abusleme et al., 2018; Choi et al., 2013) . In mice, myeloid STAT3 deficiency was causatively associated with chronic enterocolitis and endotoxic shock (Gao et al., 2018) . Due to its central importance in anti-bacterial responses and other vital biological processes, STAT3 activity is reasonably fine-tuned by multiple layers of mechanisms. The activation of STAT3 is primarily initiated by phosphorylation of its C-terminal at Tyr 705 under the effect of Janus-activated kinases (JAK) or phosphorylation at Ser 727 by protein kinase C (PKC), mitogen-activated protein kinases (MAPKs), and CDK5 (Kosack et al., 2019) . In addition to the phosphorylation, other post-translational modifications such as methylation, acetylation, and ubiquitination were recently discovered and played essential roles in controlling STAT3 activity. For example, the histone-modifying enzymes, SET domain containing lysine methyltransferase 9 (SET9) and enhancer of zeste homolog 2 (EZH2), exhibited to methylate and regulate STAT3 activity (Yuan et al., 2005; Dasgupta et al., 2015) . The deacetylase Sirtuin1 can also deacetylate and hence inhibit STAT3 activity, resulting in the restricted Th17 cell differentiation (Limagne et al., 2017) . Ubiquitination is a highly conserved posttranslational modification that emerges as a regulatory mode for STAT3 activity. Ubiquitin is a 76-amino acid protein conjugated to a wide variety of substrates and thereby influences vital signaling pathways (Malynn and Ma, 2010) . Among the most studied polyubiquitinations, Lys48 (K48)-linked ubiquitination enables proteasome-mediated degradation of targeted proteins, whereas K63-linked ubiquitination contributes to protein stabilization and signaling transduction (Heaton et al., 2016) . STAT3 has been conjugated with K63ubiquitin by the E3 ligase tumor-necrosis-factor-receptor-associated factor 6 (TRAF6) during the response to Salmonella infection (Ruan et al., 2017) . Also, Hectd3-mediated non-degradative ubiquitination constituted the prerequisite for STAT3 activation and contributed to Th17 responses and the resultant neuroinflammatory diseases (Cho et al., 2019) . These data highlight the importance of the ubiquitination in modulating STAT3 activity, but the exact role and action mode of STAT3-Ub remain to be addressed.
In the present study, we identified a small non-coding RNA, miR-127 Shi et al., 2017) , as a regulator of host defensive response, which conferred a profound protection against staphylococcal pneumonia. Specifically, miR-127 remarkably enhanced macrophage bactericidal activity and the generation of IL-22, IL-17, and anti-microbial peptides, the responses essentially driven by STAT3 pathway. Importantly, we demonstrated that the ubiquitin-editing enzyme A20, a genuine target of miR-127, physically interacted with STAT3 and downregulated K63-ubiquitination and hence phosphorylation of STAT3, leading to the compromised anti-bacterial responses and the exacerbated pneumonia. Thus, our study not only identifies miR-127 as a modulator of host innate immunity but also elucidates a regulatory circuitry that integrates STAT3 phosphorylation, ubiquitination, and non-coding miRNA to shape the optimized anti-microbial response.
RESULTS

MiR-127 Promotes Bacterial Clearance and Protects Mice from Staphylococcal Pneumonia
To explore the potential role for miR-127 in host defense against bacterial infection, we exploited murine staphylococcal pneumonia model. The result showed that intratracheal delivery of miR-127 mimic caused the enhanced proinflammatory reaction upon infection, as manifested by a remarkable increase in cellular infiltration and bronchoalveolar lavage fluid (BALF) levels of inflammatory cytokines such as IL-6 and tumor necrosis factor (TNF) a. By contrast, miR-127 inhibition led to the decreased cellular infiltration and lower levels of inflammatory cytokines ( Figures 1A-1D ). Bacterial loads, however, were reduced upon miR-127 administration and increased with anti-miR-127 treatment ( Figure 1E ). Consistently, mice with miR-127 administration displayed less body weight loss and the improved tissue pathology, whereas those treated with anti-miR-127 exhibited more weight loss and exacerbated tissue damage ( Figures 1F and 1G) , as evidenced by increased inflammatory cell infiltration, more prominent alveolar edema, and lung tissue disintegrity. Accordingly, the survival rate of mice was elevated upon miR-127 administration while decreased upon anti-miR-127 treatment when challenged with lethal dose of S. aureus ( Figure 1H ). The results thus supported a protective role of miR-127 against staphylococcal pneumonia.
Considering that IL-22 and the associated effector molecules are essential for host dense against bacterial infection (Cho et al., 2010; Treerat et al., 2017) , we then wondered whether miR-127 impacted the generation of these cytokines. Remarkably, miR-127 administration boosted while anti-miR-127 treatment suppressed lung levels of IL-22 and the related cytokine IL-17 and IL-23 in S. aureus-infected mice ( Figure 1I ). Congruent with this, the expression of anti-microbial molecules such as regenerating islet-derived protein 3b (Reg3b) and S100 calcium binding protein A8 (S100A8) as well as inducible nitric oxide synthase (iNOS) and interferon-g (IFNg) was enhanced by miR-127 overexpression and reduced by miR-127 inhibition (Figure 1J) . Taken together, we herein provided the evidences to demonstrate a protective role of miR-127 during staphylococcal pneumonia, which was likely associated with its promotion of pathogen clearance and maintenance of tissue integrity.
miR-127 Increases Macrophages Inflammatory Responses in Response to Staphylococcal Infection
Given the importance of macrophages in host defense against bacterial infection (Preston et al., 2019; Schmaler et al., 2011; Chan et al., 2018) , we next assessed the influence of miR-127 on macrophage activity during staphylococcus infection. Firstly, we noted that miR-127 was induced, in a time-dependent and does-dependent manner, in murine macrophage cell lines-RAW264.7 cells-upon infection (Figure 2A ). This expressive profile was also observed in alveolar macrophages (AMs), either in vivo or in vitro (Figure 2B) . Also, miR-127 was induced in murine bone-marrow-derived macrophages (BMDMs) ( Figure 2C ) and human monocytic cell line THP1 ( Figure 2D ), implying the involvement of miR-127 in macrophage anti-bacterial responses. Indeed, administration of miR-127 significantly increased the expression of proinflammatory cytokines IL-6, TNFa, and IL-1b but decreased the expression of anti-inflammatory cytokine IL-10 ( Figure 2E ). By contrast, the interference of miR-127 expression enabled macrophages to produce lower level of pro-inflammatory cytokines, whereas higher level of IL-10 ( Figure 2F ). In agreement with this, the activation of nuclear factor-kappa B (NF-kB), as manifested with both p-p65 level ( Figure 2G ) and p65 nuclear translocation ( Figure 2H ). The results further demonstrate that the level of phosphorylated p65 was enhanced in miR-127-expressing macrophages but decreased in miR-127-silenced cells upon infection. The similar regulatory effect of miR-127 was also observed in the activation of mitogen-activated (E-I) RAW264$7 cells were transfected with miR-127, anti-miR-127, or their non-specific controls (NC) for 24 h and then stimulated with S. aureus (MOI = 1) for the indicated time periods. The production of the indicated cytokines in cell culture supernatant was examined by ELISA (E and F). The levels of the indicated proteins involved in the NF-kB signaling were detected by immunoblotting (G). The nuclear translocation of p65 was detected by the confocal methods. Scale bar, 10 mm (H). Levels of indicated proteins involved in the MAPK signaling were detected by immunoblotting (I).
Results are from at least three independent experiments and expressed as mean G SD. *p < 0.05, **p < 0.01 by Student's t test. Representative images are shown in G-I. protein kinases (MAPKs), the other major pro-inflammatory pathway involved in the anti-bacterial response ( Figure 2I ). Together, our data indicated that miR-127 boosted macrophages inflammatory response at the early stage of staphylococcus infection.
miR-127 Enhances Bactericidal Activity and the Generation of Anti-microbial Molecules in Macrophages
We next examined the impact of miR-127 on bacterial clearance ability in macrophages. For this purpose, we initially evaluated phagocytic activity of macrophages using fluorescein isothiocyanate (FITC)-labeled S. aureus. The result showed that neither miR-127 overexpression nor miR-127 inhibition substantially affected the amounts of the internalized bacterium ( Figure 3A) , indicating that miR-127 had no apparent impact on macrophage phagocytosis. However, the enumeration of bacterial colony-forming unit (CFU) revealed that miR-127 administration significantly decreased bacterial loads, whereas anti-miR-127 treatment elevated bacterial burden during the infectious course of 18 h ( Figure 3B ). To further assess bactericidal capability of macrophages, we carried out the lysostaphin protection assay wherein the survival of internalized bacteria was visualized with fluorescent microscopy . Remarkably, the amounts of alive bacteria were less in miR-127-treated macrophages but increased in anti-miR-127-treated macrophages compared with that in non-specific (NC)-treated cells (Figures 3C and 3D) , indicating that miR-127 enhanced macrophage ability to eliminate invading bacteria.
Accumulating evidences have demonstrated that anti-microbial peptides (AMPs) played a central role in limiting bacterial replication and preventing tissue damage (Madouri et al., 2018; Berger et al., 2018) . We therefore assessed the effect of miR-127 on the production of AMPs and initially analyzed the level of IL-22, the presumed inducer of AMPs such as Reg3b and S100A8. Remarkably, the level of IL-22, as well as the related cytokine IL-17 and IL-23 was enhanced upon miR-127 treatment while reduced by miR-127 inhibition in S. aureus-infected macrophages ( Figures 3E and 3F) . Consistently, the expression of the effector molecules with anti-bacterial property, such as S100A8, Reg3b, and iNOS, was increased in miR-127-expressing macrophages but decreased in miR-127-silenced cells ( Figures 3G and 3H ). To further test the regulatory role of miR-127 in human anti-bacterial innate immunity, we then applied human monocytic cell line THP1. The results consistently demonstrated that miR-127 treatment reduced while anti-miR-127 application increased bacterial loads ( Figure 3I ), conversely correlating with the expression of anti-bacterial cytokine IL-22 and IL-17 ( Figure 3J ) and anti-microbial peptide S100A8 and Reg3b (Figure 3K ). Collectively, our data supported that miR-127 potentially enhances bacterial clearing ability in macrophage and strengthens their production of anti-microbial effector molecules.
MiR-127 Boosts Anti-bacterial Signaling through Regulating STAT3 Activity
Next, we sought to understand the mechanism exploited by miR-127 to regulate the production of anti-microbial effector molecules by macrophages. Because STAT3 signaling played an essential role in triggering IL-22 and subsequently AMPs production (Abusleme et al., 2018; Choi et al., 2013; Frey-Jakobs et al., 2018; Zhao et al., 2018) , we wondered whether miR-127 would enhance anti-microbial response via modulating STAT3 activity. Indeed, our data demonstrated that miR-127 treatment significantly enhanced phosphorylation of STAT3, whereas knockdown of miR-127 suppressed its activation ( Figures 4A and 4B ). To confirm the functional importance of the miR-127/STAT3 axis, we then utilized STAT3-specific inhibitor JSI-124 (JSI) to evaluate its role in anti-bacteria response. As shown in Figure 4C , miR-127-induced elevation in IL-17, IL-22, and Reg3b expression was largely abrogated by JCI treatment. Associated with this, the reduced bacterial burden upon miR-127 treatment was abolished either by STAT3 inhibition or by the neutralization of IL-22 or IL-17 ( Figure 4D ). Thus, the augmented anti-bacterial activity of miR-127 was largely mediated by its regulation of STAT3 signaling.
Then the question arose on how miR-127 modulated STAT3 activity during macrophage response to bacterial infection. It appeared that STAT3 was not directly targeted by miR-127 because its expressive level was unaltered upon the treatment of miR-127 or anti-miR-127. To find out the causative link between miR-127 and STAT3, we turned to the Targetscan database and focused on the ubiquitin-editing enzyme A20, which harbored a putative site complementary to the seed sequences of miR-127 gene within its 3 0 untranslated region (UTR) ( Figure 4E ). To confirm the direct regulation of A20 by miR-127, we then constructed the A20 3 0 UTR-containing reporter plasmid and found that A20-driven luciferase activity was markedly reduced by miR-127 treatment but increased upon miR-127 inhibition, substantiating the specification regulation of A20 by miR-127 ( Figure 4F ). To be supportive, A20 protein level was decreased by miR-127 treatment and elevated by anti-miR-127 administration ( Figure 4G ). MiR-127-mediated increased expression of anti-bacterial molecules IL-17, IL-22, and Reg3b was largely abrogated upon A20 overexpression, further supporting the functional relevance of the miR-127/A20 in anti-bacterial signaling ( Figure 4H) . Together, the ubiquitin-editing enzyme A20 was identified as a bona fide target of miR-127 and mediates the regulation of anti-bacterial reaction. (G) The abundance of A20 protein was detected in RAW264$7 cells that were transfected with miR-127, anti-miR-127, or their respective non-specific controls respectively, followed by S. aureus challenge for the indicated time periods. (H) A20-expressing or control plasmids were introduced into RAW264$7 cells that were treated with miR-127 or nonspecific control (NC). The levels of representative anti-microbial molecules were analyzed 12 h after staphylococcal infection. All results are from three independent experiments and presented as mean G SD. *p < 0.05, **p < 0.01 by Student's t test.
A20 Physically Interacts with STAT3 and Represses Its Ubiquitination and Hence Activation
the ubiquitinative modification (Cho et al., 2019; Ruan et al., 2017) , we postulated that miR-127 might regulate STAT3 signaling through A20-mediated ubiquitination. To test this, we detected the direct interaction between STAT3 and A20 by Co-IP test. Prominently, A20 was recruited and bond to STAT3 and as a result, repressed the K63-ubiquitination of STAT3 ( Figures 5A and 5B) . By contrast, the knockdown of A20 led to the enhanced ligation of K63-linked polyubiquitin chains to STAT3 ( Figure 5C ). Congruently, A20 overexpression suppressed, whereas A20 knockdown increased phosphorylation of STAT3 in response to staphylococcal infection ( Figure 5D ), suggesting that A20 regulated STAT3 activation via its de-ubiquitinase activity. To further confirm this, we generated the mutation A20-expression plasmid with the C103S substitution within the ovarian tumor (OUT) domain, the structure responsible for A20 de-ubiquitinase activity (Voet et al., 2018) . The result showed that A20-mediated de-ubiquitination of STAT3 was substantially impaired when transfected with the OUT-mutant plasmids, and the repressed STAT3 phosphorylation was accordingly resumed ( Figure 5E ). Together, we demonstrated that the ubiquitin-editing enzyme A20 specifically interacted with STAT3 and suppressed STAT3 ubiquitination and hence activation in response to bacterial infection.
The Involvement of the miR-127/A20/STAT3 Axis in the Development of Staphylococcal Pneumonia
We next valuated the in vivo functional relevance of the miR-127/A20/STAT3 pathway by exploiting murine model of staphylococcal pneumonia. To this end, miR-127, anti-miR-127, or their non-specific control Figure 5 . A20 Physically Interacts with STAT3 and Regulates Its Ubiquitination and Hence Activation in Response to Staphylococcal Infection (A) 293T cells were transfected with STAT3-and/or A20-expressing plasmids for 48 h. Cells were then lysed for co-immunoprecipitation (co-IP) of STAT3 with anti-A20 antibody or for co-IP of A20 with anti-STAT3 antibody. (B and C) 293T cells were transfected with STAT3-and/or A20-expressing plasmids (B) or transfected with A20-specific siRNA (C) for 48 h. The level of K63-ubiquitinated STAT3 was detected by co-IP. (D) The level of phosphorylated STAT3 was detected in RAW264$7 cells transfected with A20-expressing plasmids or A20specific siRNA or their controls. (E) RAW264$7 cells were transfected with the intact or mutant (C103S) A20-expressing plasmids. The levels of total and phosphorylated STAT3 and K63-ubiquitinated STAT3 were examined. Shown are the representatives of two or three similar experiments. IgG was used as a negative control. nucleotides (NC) were intratracheally instilled into mice 24 h prior to S. aureus infection, and the levels of A20 and total and phosphorylated STAT3 were analyzed in murine lung tissues. The result showed that the intratracheal administration of miR-127 reduced, whereas anti-miR-127 treatment elevated the level of A20 upon staphylococcus infection ( Figures 6A and 6B) . Meanwhile, the intensity of phosphorylated STAT3 was augmented upon miR-127 treatment but weakened on miR-127 inhibition, correlating inversely with A20 expression ( Figure 6C ). The positive correlation between the levels of miR-127 and phosphorylated STAT3 was also observed in murine lung tissues ( Figure 6D) . Combined with the protective role of miR-127 during staphylococcal infection observed above ( Figures 1A-1J ), we thus proposed a regulatory paradigm wherein A20, a genuine target of miR-127, restrained STAT3 activity through the repression of its K63-conjugated ubiquitination, and the induction of miR-127 upon infection led to the de-repression of this restraint and the facilitation of the anti-bacterial signaling ( Figure 6E ).
DISCUSSION
The growing problem of antibiotic resistance in obstinate pathogens such as MRSA and the poor pipeline of antimicrobial molecules ignite the enthusiasm to develop therapeutic strategies, which demands more knowledge about host defensive machinery in addition to pathogenic factors. In this study, we identify miR-127 as a regulator of host anti-bacterial innate immunity and illustrate its functional importance and action mode in combating drug-resistant staphylococcus. Specifically, our data demonstrated that miR-127, induced upon infection, expedited clearance of bacteria and protected mice against pneumonia, whereas inhibition of miR-127 rendered mice more prone to staphylococcal infection with higher bacterial burden and exacerbated pneumonia. Importantly, we showed that A20, a genuine target of miR-127, repressed STAT3-mediated anti-bacterial signaling through constraining K63-ligated ubiquitination and hence activation of STAT3. We thus discover an unappreciated regulatory paradigm linking non-coding miRNA and STAT3 ubiquitination and phosphorylation that has a key role in coordinating anti-microbial immunity. The findings extend our understanding about host-pathogen interaction and provide potential targets for combating highly drug-resistant bacteria such as MRSA (Baral et al., 2018; Liu et al., 2018) .
MicroRNAs (miRNAs) are short, conserved, non-coding RNA molecules with the potential to regulate mRNA stability and/or translation (Seeley et al., 2018) . A number of miRNAs such as miR-302, miR-155, miR-223, miR-146, and miR-122 have demonstrated to be essential in the regulation of macrophage activity and innate immune responses (Rothchild et al., 2016; Liu et al., 2012; Wang et al., 2019a Wang et al., , 2019b . Nevertheless, previous studies mainly center on the effect of miRNA on inflammatory signaling. Evidences are emerging to delineate the direct effect of miRNAs, such as miRNA-328, on anti-microbial responses (Tay et al., 2015) , but the related clues are relatively scarce. Our discovery that a small non-coding RNA, miR-127, plays a key role in regulating anti-bacterial pathway through the A20/STAT3 axis confers insights into microRNA biology in the field of innate immunity. The finding however seems odd since miRNA is generally considered as the regulator of gene expression rather than as the ''on-off switcher.'' In this regard, we show the de-ubiquitinase A20 exerts a central role that translates the miRNA-mediated gene regulation into the signaling modulation dependent on its de-ubiquitinase activity. In particular, our data indicate that A20 specifically interacted with STAT3 and inhibited the conjugation of K63-ubiquitin to STAT3, which in turn promoted STAT3 activation in response to staphylococcal infection. Although phosphorylation of STAT3 at Tyr705 or Ser727 has been identified as essential step for STAT3 activity, other post-translation modification and their relevance to STAT3 activation remain to be explored (Cho et al., 2019; Dallavalle et al., 2016; Ruan et al., 2017) . We herein prove that de-repression of A20-mediated restraint of STAT3 ubiquitination is required for STAT3 activation and hence anti-bacterial signaling. The finding supports that integration of multiple layers of regulation such as ubiquitination and phosphorylation are essential for fine-tuning of STAT3, given its pleotropic function and its implication in pathophysiological conditions when dysregulated. In addition, we note that miR-127 is induced by staphylococcal infection in a dose-and time-dependent manner. Our previous study indicated that the induction of miR-127 was essentially dependent on NF-kB , the pathway known to be suppressed by A20. Thus, A20 likely serves as a molecular rheostat to be overcome to induce miR-127 production, which is essentially dependent on the infectious or inflammatory signals sensed and transduced into cells (Huynh et al., 2019) .
As is known, the inflammatory response is indispensable for immune cells recruitment and anti-microbial response, but uncontrolled inflammatory signaling results in tissue damage, inflammapathology, and lethality (Branchett and Lloyd, 2019) . In the present study, we found that in addition to anti-microbial response, miR-127 also promoted inflammatory cytokines production and inflammatory cells infiltration. Intriguingly, the amplified inflammatory response did not jeopardize but improve disease manifestation, as evidenced by alleviated lung immunopathology, lessened weight body loss, and decreased mortality upon intratracheal miR-127 administration. This is likely due to the tissue-protective effect of IL-17, IL-22, and AMPs such as Reg3b and S100A8, the molecules with particular importance in tissue repairing, regeneration, and mucosal barrier integrity Dudakov et al., 2015; Loonen et al., 2014; Sechet et al., 2018; Cho et al., 2010) . Indeed, pro-inflammatory cytokines such as IL-6, TNFa, and IL-1b have demonstrated to play an instructive role in the generation of anti-microbial cytokines or other effector molecules and contribute to infection resolution. For instance, TNFa, induced by the recruited monocytes, was required for the production of IL-17, macrophage phagocytosis, and bacterial clearance, and hence recovery from pneumonia (Xiong et al., 2016) . Likewise, IL-6 exhibited the ability to promote IL-17/IL-22-mediated anti-microbial responses through stimulating STAT3 signaling (Saint-Criq et al., 2018) . The defective production of IL-6, induced by pathogenic component LasB of Pseudomonas aeruginosa, resulted in defective STAT3 activation and compromised anti-bacterial reactivity. These data, combined with our current findings, demonstrate a coherent link between NF-kB-driven proinflammatory signaling and STAT3mediated anti-microbial pathway, which ensures defensive response at appropriate magnitude and kinetics to avoid unresolved infection (Ji et al., 2019) . As an additional support, a recent study demonstrated that TRAF6, the E3 ligase required for NF-kB activation, exerted a boosting role in STAT3 activation through enhancing K63 ubiquitin (Ruan et al., 2017) . Interestingly, it has been demonstrated that the deubiquitinase A20 can counteract the activity of TRAF6 through removing K63-ubiquitin from the subsets and feedback regulate vital signal pathways driven by NF-kB and TGF-b1/Smad6 (Shembade et al., 2010; Jung et al., 2013) . Whether the A20/TRAF6 axis is involved in the regulation of STAT3 activity or not merits further investigation.
Taken together, our study identifies miR-127 as a key regulator of host defense against staphylococcus infection and delineates a regulatory circuitry that integrates non-coding miRNA and STAT3 ubiquitination/phosphorylation to shape the optimized anti-bacterial response. The findings are believed to have both biological and clinical implications and may provide therapeutic options for highly anti-antibiotic pathogens such as MRSA.
Limitations of the Study
Our current study elucidates a regulatory mechanism mediated by the miR-127/A20/STAT3 axis, which plays a key role in modulating macrophage anti-bacterial responses. However, as STAT3-driven anti-microbial signaling is also triggered by other immune cell subsets such as innate lymphoid cells and gd T cells (Baral et al., 2018; Xiong et al., 2016; Paudel et al., 2019) , we currently cannot exclude the effect of miR-127 on these cells' response to bacterial infection, the topic of which is currently under investigation in our lab.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci. 2019.100763. Tong, S.Y., Davis, J.S., Eichenberger, E., Holland, T.L., and Fowler, V.G., Jr. (2015) . Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28, 603-661. Treerat, P., Prince, O., Cruz-Lagunas, A., Munoz-Torrico, M., Salazar-Lezama, M.A., Selman, M., Fallert-Junecko, B., Reinhardt, T.A., Alcorn, J.F., Kaushal, D., et al. (2017) . Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection. Mucosal Immunol. 10, 1069-1081.
Vaishnava, S., Yamamoto, M., Severson, K.M., Ruhn, K.A., Yu, X., Koren, O., Ley, R., Wakeland, E.K., and Hooper, L.V. (2011) . The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. 
Preparation of S. aureus
The MRSA strain USA300 was kindly provided by Pro. Feng Xu (School of Medicine, Zhejiang University), and was grown to the stationary growth phase at 37°C in Luria-Bertani broth, then harvested by centrifugation (8000 rpm, 5 min). The bacteria were washed by PBS for 3 times and re-suspended in PBS, of which the densities were estimated at OD600. (Xu et al., 2013) Staphylococcal infection model (Xu et al., 2013) For pulmonary bacterial infections, a total volume of 50 μL of PBS containing S. aureus (5×10 6 CFU/mice) was intratracheally administered into mice. In some cases, mice were pretreated with a total volume of 50 μL of PBS containing miR-127 mimic, miR-127 inhibitors, and nonspecific controls (NC) (2mg/kg) respectively. For the mortality studies, the mice were intratracheally instilled with 1×10 8 CFU/mice of S. aureus. The survival rate of mice was monitored every 4 h.
Bronchoalveolar lavage and cell differentiation(Ying et al., 2015)
Briefly, murine trachea was exposed through the midline and cannulated with a sterile needle (1mL). Bronchoalveolar lavage fluid (BALF) was obtained by flushing the lungs three times with 1 mL EDTA/PBS (0·5 mM). After centrifugation, BALF supernatants were stored at -80°C for use. Total cell numbers in BALF were counted by the hemocytometer, and neutrophils in BALF were assessed through immunostaining and flow cytometry.
Cell preparation and culture
The RAW264·7 (ATCC® TIB-71™) and 293T (ATCC® CRL-3216™) cell lines were obtained from American Type Culture Collection and have been authenticated and tested for mycoplasma contamination. RAW264·7 and 293T cells were cultured in DMEM medium containing 10% fetal bovine serum (FBS). For alveolar macrophages (AMs), the collected BALF were centrifuges, washed and plated in 12-well plates, and AMs were selected by adherence after repeated washing
Plasmids or miRNA transfection
For plasmids transfection, RAW264·7 or 293T cells were transiently transfected with the indicated plasmids using X-treme GENE HP DNA Transfection Reagent (Roche). MiR-127 mimics, miR-127 inhibitors, and non-specific RNA were transfected into macrophages using siPORT TM NeoFXTM transfection reagents (Invitrogen) according to standard protocols. The knock-in or knock-down efficacy was determined by qPCR or immunoblotting assay.
Quantitative PCR
Total RNA was isolated using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) according to manufacturer's instructions. First-strand cDNA was synthesized using PrimerScript II 1st Stand cDNA Synthesis Kit (Takara, Tokyo, Japan). Quantitative real-time PCR was performed using SYBR Green PCR Master Mix (TOYOBO) to detect mRNA levels of target genes. The data were normalized to β-actin or U6 and determined by the ΔΔCt method. The primers used in the study were synthesized by Genepharma TGTCCTCAGTTTGTGCAGAATATAAA and 5'-TCACCATCGCAAGGAACTCC; Reg3γ: 5'-CGTGCCTATGGCTCCTATTGCT and '-TTCAGCGCCACTGAGCACAGAC; β-Defensin-1: 5'-TAGTCTCTTCATCTGTGTTTTTGCATA and 5'-TTCAGCGCCACTGA GCACAGAC; β-Defensin-3: 5'-CCAGGCTGATCCTATCCAGG and 5'-GTCCCATTCAT GCGTTCTCT; β-defensin-4: 5'-TGGCCTCCAAAGGAGATAGACA and 5'-AGGCTG ATCCTATCCAAAACACA.
Plasmids construction and dual luciferase reporter assays
The cDNA encoding mouse A20 were inserted into pcDNA3·1 vector (Invitrogen) to construct the expressing plasmid. To construct A20-driven reporter plasmid, a 1500 bp fragment of A20 5'UTR was amplified from murine genomic DNA and cloned into pMIR REPORT Vector (Ambion). MiR-127 mimics, anti-miR-127, or non-specific control (NC) nucleotides were transfected respectively into RAW 264·7 cells using X-treme GENE DNA transfection reagent, along with pMIR-A20 or control pMIR plasmids. Cells were then infected with S. aureus (MOI 1) for 6 h and collected for dual-Luciferase reporter assay (Promega).
Determination of cytokine levels
The levels of TNFα, IL-6, IL-1β, and IL-10 in the cell culture supernatants and BALF were measured by ELISA kits (R&D Systems) according to manufacturers' instructions.
Immunoblotting and co-immunoprecipitation assay
Cell lysates were prepared by lysis buffer (1% Triton X-100, 1% deoxycholate, 0·1% NaN3) containing protease inhibitor cocktail tablets (Roche Diagnostics). Equal amounts of total protein were separated on 10% SDS-polyacrylamide mini-gels and transferred onto Immobilon PVDF membranes (Millipore). After blocked in Tris-buffered saline with Tween-20 (TBST) containing 5% DifcoTM Skim Milk (BD), membranes were incubated with appropriate primary antibodies overnight, followed by the incubation of secondary antibody conjugated with horseradish peroxidase. The signals were visualized using Millipore™ Immobilon™ Western Chemiluminescent HRP Substrate (ECL). For immunoprecipitation studies, cell lysates were incubated at 4°C for 2 h with a capture antibody or a control IgG, followed by overnight incubation with Dynabeads™ Protein A.
The immunocomplexes were collected by centrifugation, washed with ice-cold PBST (PBS-0.02% Tween-20), and separated by SDS-PAGE. The samples were detected by the standard immune-blotting methods.
Internalization and killing of bacteria
To assess the phagocytic capability, macrophages were incubated with CFSE-labeled S. aureus (MOI 10) at indicated time periods. Infected cells were washed, and extracellular bacteria were eliminated by treatment of lysostaphin (20 μg/mL). Macrophages were then collected and intracellular bacteria loads were quantified by flow cytometry (FACS Calibur, BD Biosciences). To determine the bactericidal capability of macrophages , cells were grown on cover slips, and incubated with CFSE-labeled S. aureus (MOI 10) for 2 h. Then, cells were washed and further cultured in fresh medium containing lysostaphin (2 μg/mL) for the indicated time periods. After that cells were fixed and the nuclear were counter-stained with DAPI, followed by the observation using fluorescence microscope. Alternatively, cells subjected to staphylococcal infection were collected, washed and lysed to determine bacterial loads using the plate-dilution methods.
Immunofluorescence staining and confocal microscopy of p65
RAW264.7 cells transfected with MiR-127 mimics, anti-miR-127 or non-specific control (NC) nucleotides for 36 h, and then seeded on slides and stimulated with S. aureus for the indicated time. Cells were then collected, fixed with 100% methanol, washed, and permeabilized in 0.2% saponin. After blocking with 5% bovine serum, cells were stained with primary rabbit anti-p65 overnight at 4°C and then stained with goat anti-rabbit IgG conjugated to Texas Red (Invitrogen), and the nuclei were labeled with DAPI (Invitrogen).
Cells were finally mounted in Vectashield and detected under fluorescence confocal microscopy (LSM confocal microscope; Carl Zeiss, Inc.).
Histologic analysis of lung tissues
For the histological analyses, mouse lung samples were washed thoroughly in PBS, fixed in 4% (wt/vol) formalin and embedded in paraffin; 5 μM sections were then stained with hematoxylin and eosin (H&E) using standard procedures. For the immunostaining, lung sections were deparaffinized, hydrated, and blocked in DPBS with 2% normal goat serum.
The slides were then stained with the indicated primary and biotin-conjugated secondary antibodies, followed by incubation with streptavidin-conjugated HRP. Slides were finally incubated with DAB reagent and counterstained with haematoxylin for observation.
Statistical analysis
All of the data, unless otherwise indicated, are presented as the means ± SD of three independent experiments. The statistical significance of the differences between two groups was analyzed with Student's t test. Multiple group comparisons were performed by one-way ANOVA followed by Bonferroni post hoc t test. The Kaplan-Meier survival analysis with a log-rank test was applied to evaluate the survival curve. All of the calculations were performed using the Prism software program for Windows (GraphPad Software). A p value of 0·05 or less was considered statistically significant. 
